- Marketwired•3 days agoLion Biotechnologies Announces 5-Year Extension of National Cancer Institute CRADA for Development of Novel TIL Immuno-Oncology Therapies
Lion Biotechnologies, Inc. , a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes , today announced an amendment of its Cooperative Research and Development ...
- Associated Press•19 days ago
The New York-based company said it had a loss of 23 cents per share. The results fell short of Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was ...
- Marketwired•19 days ago
Company appointed new CEO, Maria Fardis, Ph.D., with deep oncology leadership experience Completed $100M equity financing and expanded Board Lion Biotechnologies, Inc. , a biotechnology company developing ...
Lion Biotechnologies, Inc. (LBIO)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
|Bid||8.01 x 3000|
|Ask||9.68 x 700|
|Day's Range||8.43 - 8.81|
|52wk Range||4.24 - 9.58|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-12.09|
|Avg Vol (3m)||569,865|
|Dividend & Yield||N/A (N/A)|